DUBLIN--(BUSINESS WIRE)--The "3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The 3D cell culture market is projected to reach USD 1,846 million by 2024 from USD 892 million in 2019, at a CAGR of 15.7%
The growth in this market is primarily driven by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to limit market growth during the forecast period.
The microfluidics-based 3D cell cultures segment is projected to grow at the highest CAGR during the forecast period.
Based on product, the 3D cell culture market is segmented into scaffold-based, scaffold-free, microfluidics-based, and magnetic & bioprinted 3D cell cultures. The microfluidics-based segment is expected to register the highest CAGR during the forecast period. Funding initiatives from various government and private investors are among the key factors driving the growth of this market.
Cancer and stem cell research segment accounted for the largest share of the 3D cell culture market in 2018.
On the basis of application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell research segment accounted for the largest share of the market in 2018. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government as well as the private sector are some of the major factors driving the growth of this application segment.
Europe to witness high growth during the forecast period.
Based on the region, the 3D cell culture market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The European market is expected to grow at the highest CAGR owing to the growth of the pharmaceutical and biotechnology industry, increasing incidence of cancer, growing number of venture capital investments, strategic expansion of market players in the region, recent commercialization of microfluidic-based products, increasing presence of major market players, and the large number of research activities in the region.
- Increasing Focus on Developing Alternatives to Animal Testing
- Growing Focus on Personalized Medicine
- Increasing Incidence of Chronic Diseases
- Availability of Funding for Research
- Lack of Infrastructure for 3D Cell-Based Research
- High Cost of Cell Biology Research
- Emergence of Microfluidics-Based 3D Cell Culture
- Emerging Economies
- Regenerative Medicine - An Alternative to Organ Transplantation
- Lack of Consistency in 3D Cell Culture Products
- Thermo Fisher Scientific
- Corning Incorporated
- Merck KGaA
- Lonza Group
- 3D Biotek LLC
- Emulate, Inc.
- CN Bio Innovations Limited
- Hamilton Company
- Insphero AG
- Kirkstall, Ltd.
- MIMETAS BV
- TissUse GmbH
- Synthecon Incorporated
- QGel SA
Other Key Players
- Greiner Bio-One International GmbH
- Promocell GmbH
- Advanced Biomatrix, Inc.
- Hrel Corporation
- Synvivo, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/aj5kod